Cargando…

Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis

Anti-centromere antibody (ACA) is one of the classical anti-nuclear antibody (ANA) staining patterns. However, characteristics of ACA in comparison with the other ANA patterns and clinical features of ACA-positive subjects have not been elucidated. Here, we examined all ANA patterns by indirect immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuramoto, Nobuo, Ohmura, Koichiro, Ikari, Katsunori, Yano, Koichiro, Furu, Moritoshi, Yamakawa, Noriyuki, Hashimoto, Motomu, Ito, Hiromu, Fujii, Takao, Murakami, Kosaku, Nakashima, Ran, Imura, Yoshitaka, Yukawa, Naoichiro, Yoshifuji, Hajime, Taniguchi, Atsuo, Momohara, Shigeki, Yamanaka, Hisashi, Matsuda, Fumihiko, Mimori, Tsuneyo, Terao, Chikashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537247/
https://www.ncbi.nlm.nih.gov/pubmed/28761166
http://dx.doi.org/10.1038/s41598-017-07137-4
_version_ 1783254133876195328
author Kuramoto, Nobuo
Ohmura, Koichiro
Ikari, Katsunori
Yano, Koichiro
Furu, Moritoshi
Yamakawa, Noriyuki
Hashimoto, Motomu
Ito, Hiromu
Fujii, Takao
Murakami, Kosaku
Nakashima, Ran
Imura, Yoshitaka
Yukawa, Naoichiro
Yoshifuji, Hajime
Taniguchi, Atsuo
Momohara, Shigeki
Yamanaka, Hisashi
Matsuda, Fumihiko
Mimori, Tsuneyo
Terao, Chikashi
author_facet Kuramoto, Nobuo
Ohmura, Koichiro
Ikari, Katsunori
Yano, Koichiro
Furu, Moritoshi
Yamakawa, Noriyuki
Hashimoto, Motomu
Ito, Hiromu
Fujii, Takao
Murakami, Kosaku
Nakashima, Ran
Imura, Yoshitaka
Yukawa, Naoichiro
Yoshifuji, Hajime
Taniguchi, Atsuo
Momohara, Shigeki
Yamanaka, Hisashi
Matsuda, Fumihiko
Mimori, Tsuneyo
Terao, Chikashi
author_sort Kuramoto, Nobuo
collection PubMed
description Anti-centromere antibody (ACA) is one of the classical anti-nuclear antibody (ANA) staining patterns. However, characteristics of ACA in comparison with the other ANA patterns and clinical features of ACA-positive subjects have not been elucidated. Here, we examined all ANA patterns by indirect immunofluorescence for 859 rheumatoid arthritis (RA) patients. Together with the ANA data of 9,575 healthy volunteers, we compared distributions of the ANA levels. ACA was the only ANA that demonstrated a definite bimodal distribution of levels. ACA showed significantly higher levels than the other ANA staining patterns in both RA and healthy population (p < 0.0001). ACA-positivity was associated with old age and was observed more in females. We further recruited another cohort of 3,353 RA patients and confirmed the findings. ACA was also associated with Raynaud’s phenomenon (p = 6.8 × 10(−11)) in RA. As a conclusion, ACA displays a specific ANA staining pattern with a bimodal distribution, and ACA-positive RA may constitute a distinct subset with specific clinical features.
format Online
Article
Text
id pubmed-5537247
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-55372472017-08-03 Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis Kuramoto, Nobuo Ohmura, Koichiro Ikari, Katsunori Yano, Koichiro Furu, Moritoshi Yamakawa, Noriyuki Hashimoto, Motomu Ito, Hiromu Fujii, Takao Murakami, Kosaku Nakashima, Ran Imura, Yoshitaka Yukawa, Naoichiro Yoshifuji, Hajime Taniguchi, Atsuo Momohara, Shigeki Yamanaka, Hisashi Matsuda, Fumihiko Mimori, Tsuneyo Terao, Chikashi Sci Rep Article Anti-centromere antibody (ACA) is one of the classical anti-nuclear antibody (ANA) staining patterns. However, characteristics of ACA in comparison with the other ANA patterns and clinical features of ACA-positive subjects have not been elucidated. Here, we examined all ANA patterns by indirect immunofluorescence for 859 rheumatoid arthritis (RA) patients. Together with the ANA data of 9,575 healthy volunteers, we compared distributions of the ANA levels. ACA was the only ANA that demonstrated a definite bimodal distribution of levels. ACA showed significantly higher levels than the other ANA staining patterns in both RA and healthy population (p < 0.0001). ACA-positivity was associated with old age and was observed more in females. We further recruited another cohort of 3,353 RA patients and confirmed the findings. ACA was also associated with Raynaud’s phenomenon (p = 6.8 × 10(−11)) in RA. As a conclusion, ACA displays a specific ANA staining pattern with a bimodal distribution, and ACA-positive RA may constitute a distinct subset with specific clinical features. Nature Publishing Group UK 2017-07-31 /pmc/articles/PMC5537247/ /pubmed/28761166 http://dx.doi.org/10.1038/s41598-017-07137-4 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Kuramoto, Nobuo
Ohmura, Koichiro
Ikari, Katsunori
Yano, Koichiro
Furu, Moritoshi
Yamakawa, Noriyuki
Hashimoto, Motomu
Ito, Hiromu
Fujii, Takao
Murakami, Kosaku
Nakashima, Ran
Imura, Yoshitaka
Yukawa, Naoichiro
Yoshifuji, Hajime
Taniguchi, Atsuo
Momohara, Shigeki
Yamanaka, Hisashi
Matsuda, Fumihiko
Mimori, Tsuneyo
Terao, Chikashi
Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis
title Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis
title_full Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis
title_fullStr Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis
title_full_unstemmed Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis
title_short Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis
title_sort anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537247/
https://www.ncbi.nlm.nih.gov/pubmed/28761166
http://dx.doi.org/10.1038/s41598-017-07137-4
work_keys_str_mv AT kuramotonobuo anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis
AT ohmurakoichiro anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis
AT ikarikatsunori anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis
AT yanokoichiro anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis
AT furumoritoshi anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis
AT yamakawanoriyuki anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis
AT hashimotomotomu anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis
AT itohiromu anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis
AT fujiitakao anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis
AT murakamikosaku anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis
AT nakashimaran anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis
AT imurayoshitaka anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis
AT yukawanaoichiro anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis
AT yoshifujihajime anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis
AT taniguchiatsuo anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis
AT momoharashigeki anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis
AT yamanakahisashi anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis
AT matsudafumihiko anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis
AT mimoritsuneyo anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis
AT teraochikashi anticentromereantibodyexhibitsspecificdistributionlevelsamongantinuclearantibodiesandmaycharacterizeadistinctsubsetinrheumatoidarthritis